Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 3,000 shares at $420.33 ($1.3M) on 2015-02-26, disclosed to the SEC on 2015-02-27.
Open-market sale of $1.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $420.33 | 1,600 | $673K | 53.1% |
| 2 | $423.64 | 1,100 | $466K | 36.8% |
| 3 | $424.44 | 300 | $127K | 10.1% |
| Total | $421.95 avg | 3,000 | $1.3M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |